InfuSystem Holdings financials
$13.03+1.24%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.9M | $33.7M | $36.2M | $36.5M | $36.0M | $34.7M | $33.8M | $35.3M | $33.7M | $32.0M | $31.8M | $31.9M |
| Gross profit | $21.4M | $19.7M | $20.4M | $20.8M | $19.9M | $19.2M | $18.2M | $19.0M | $16.7M | $16.5M | $16.7M | $15.6M |
| Gross margin | 58.0% | 58.4% | 56.4% | 57.1% | 55.2% | 55.2% | 53.8% | 53.9% | 49.5% | 51.5% | 52.6% | 48.9% |
| Operating income | $4.2M | $1.6M | $3.7M | $3.8M | $3.8M | $618.0K | $2.6M | $3.3M | $1.9M | -$845.0K | $1.3M | $1.7M |
| Net income | $3.2M | $1.0M | $2.0M | $2.3M | $2.6M | -$267.0K | $933.0K | $1.8M | $717.0K | -$1.1M | $72.0K | $689.0K |
| Net margin | 8.7% | 3.0% | 5.6% | 6.2% | 7.2% | −0.8% | 2.8% | 5.1% | 2.1% | −3.5% | 0.2% | 2.2% |
| Diluted EPS | $0.15 | $0.05 | $0.10 | $0.11 | $0.12 | $-0.01 | $0.04 | $0.08 | $0.03 | $-0.05 | $0.00 | $0.03 |
| EBITDA | $7.3M | $4.8M | $7.1M | $7.1M | $7.1M | $3.9M | $6.0M | $6.4M | $4.9M | $2.1M | $4.4M | $4.8M |
| Operating cash flow | $6.8M | $970.0K | $7.1M | $8.5M | $7.0M | $1.8M | $7.9M | $9.8M | $2.3M | $377.0K | $4.7M | $4.3M |
| Free cash flow | $1.8M | -$867.0K | $4.2M | $7.4M | $5.8M | -$1.6M | $2.8M | $6.4M | -$5.3M | -$1.3M | $2.7M | $2.6M |
| Diluted shares | 20.9M | 20.9M | 21.3M | 20.9M | 21.1M | 21.1M | 22.2M | 21.7M | 21.7M | 21.2M | 22.4M | 21.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $964.0K | $2.1M | $3.2M | $955.0K | $720.0K | $1.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $20.4M | $19.6M | $19.6M | $20.9M | $26.3M | $28.7M |
| Total assets | $97.7M | $98.7M | $100.6M | $98.9M | $100.8M | $104.3M |
| Total liabilities | $38.6M | $39.9M | $43.2M | $43.4M | $46.3M | $49.1M |
| Shareholders' equity | $59.1M | $58.7M | $57.3M | $55.5M | $54.5M | $55.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology